Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study. [electronic resource]
Producer: 20090611Description: 514-26 p. digitalISSN:- 0149-2918
- Administration, Topical
- Adolescent
- Adult
- Anti-Bacterial Agents -- administration & dosage
- Azepines -- administration & dosage
- Child
- Colony Count, Microbial
- Conjunctivitis, Bacterial -- drug therapy
- Double-Blind Method
- Drug Administration Schedule
- Female
- Fluoroquinolones -- administration & dosage
- Humans
- Male
- Microbial Sensitivity Tests
- Middle Aged
- Ophthalmic Solutions
- Ophthalmoscopy
- Pharmaceutical Vehicles -- administration & dosage
- Prospective Studies
- Time Factors
- Treatment Outcome
- United States
- Visual Acuity -- drug effects
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.